Gilead's $2,340 Price For Coronavirus Drug Remdesivir Draws CriticismThe Bay Area maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course.
US Government's Supply Of COVID-19 Drug Remdesivir Runs Out At End Of MonthFoster City-based Gilead Sciences, the company that makes the drug, is ramping up to make more, but it's unclear how much will be available this summer.
Gilead Says Drug Remdesivir Helped Moderately Ill Coronavirus PatientsA Bay Area biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
Most COVID-19 Patients In Experimental Gilead Drug Trial Recovering QuicklyBay Area biotech company Gilead Sciences is in the spotlight after the firm's drug remdesivir got positive results in a trial treatment on COVID-19 patients. But some experts are not celebrating yet.
Coronavirus Patients Rush To Join Studies Of Gilead Drug RemdesivirCoronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.
WHO: Gilead Sciences Drug May Help Treat Coronavirus SymptomsAn official from the World Health Organization said that Gilead's drug remdesivir is showing signs that it may be able to help treat the deadly coronavirus.
Chinese Scientists Ask For Patent On Gilead Sciences Drug To Fight CoronavirusScientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Sciences Inc. to treat the disease.
Gilead Sciences Testing Antiviral Drug To Treat CoronavirusThere is no cure for the deadly Wuhan coronavirus, but several big biotech companies are hoping they can treat the symptoms with existing antiviral medications.
Gilead Cashes In On HIV Treatment Patented By GovernmentA pricey HIV drug patented by the government is making billions for the manufacturer, Foster City-based Gilead, while the drug remains out of reach for many.
FDA Approves Gilead’s Latest Combo HIV Pill DescovyThe Food and Drug Administration has approved Descovy, a combination HIV drug developed by biologic drugmaker Gilead Sciences.
Biotech Miracle Drugs Raise The Literal Cost Of Living Beyond Medicaid's ReachA newly-approved drug being hailed as a major advance in treatment of cystic fibrosis comes with a punishing price tag: about $710 per patient per day.
Gilead Sciences Doubles Its Profit To $12.1 Billion On Strength Of $1,000 Per Pill Hepatitis DrugA Bay Area pharmaceutical firm is among other top drug makers facing scrutiny over enormous profits, the price charged for drugs, and how much the company spends on marketing versus research and development.
San Francisco Supervisor Scott Wiener Goes Public About His Use Of HIV Prevention DrugIn what some HIV experts calling a courageous move, San Francisco Supervisor Scott Wiener has gone public with news that he's taking the HIV prevention drug Truvada, saying the idea is to raise awareness that this treatment could save lives.
Oregon, Illinois Medicaid Programs Place Tight Restrictions On Gilead $1,000-Per-Pill Hepatitis C Drug SovaldiAn Oregon Medicaid committee is expected Thursday to significantly scale back access to an effective—but expensive—new drug used to treat hepatitis C, the second state to retrict access to the drug in two days.
Foster City-Based Gilead's Breakthrough Hepatitis Drug Costs $1,000 Per Pill Doctors are calling a newly-approved drug a “ revolution” in treating the most common blood-borne infection in the United States. But patient advocates warn how those who need it may not be able to afford it; and noisy protests from Paris to San Francisco are trying to drive the displeasure over the price into the open.